Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Paulo H. Verardi"'
Autor:
Julianna Herman, Nicole Rittenhouse, Francesca Mandino, Mushirah Majid, Yuxiang Wang, Amelia Mezger, Aidan Kump, Sumeet Kadian, Evelyn M. R. Lake, Paulo H. Verardi, Joanne C. Conover
Publikováno v:
Frontiers in Neuroscience, Vol 18 (2024)
Congenital post-infectious hydrocephalus (PIH) is a condition characterized by enlargement of the ventricular system, consequently imposing a burden on the associated stem cell niche, the ventricular-subventricular zone (V-SVZ). To investigate how th
Externí odkaz:
https://doaj.org/article/5eefa331e7a4422da360392019395345
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
Abstract Zika virus (ZIKV), a flavivirus transmitted primarily by infected mosquitos, can cause neurological symptoms such as Guillian–Barré syndrome and microcephaly. We developed several vaccinia virus (VACV) vaccine candidates for ZIKV based on
Externí odkaz:
https://doaj.org/article/0579b072da9c435fb3f374dfe50845f0
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 17, Iss , Pp 731-738 (2020)
Vaccinia virus (VACV) was successfully used as a vaccine in the smallpox eradication campaign. Since then, it has been widely used in the development of vaccine and therapeutic vectors. However, methods of generating and purifying recombinant VACVs (
Externí odkaz:
https://doaj.org/article/20564782805d4bf389b34a810fa140b0
Publikováno v:
Pathogens, Vol 11, Iss 12, p 1505 (2022)
As demonstrated by the 2015 Zika virus outbreak in the Americas, emerging and re-emerging arboviruses are public health threats that warrant research investment for the development of effective prophylactics and therapeutics. Many arboviral diseases
Externí odkaz:
https://doaj.org/article/1ec8a532368b47bf844d1d30203231b2
Autor:
Junru Cui, Caitlin M. O’Connell, Connor Hagen, Kim Sawicki, Joan A. Smyth, Paulo H. Verardi, Herbert J. Van Kruiningen, Antonio E. Garmendia
Publikováno v:
Vaccines, Vol 8, Iss 1, p 106 (2020)
Background: Porcine reproductive and respiratory syndrome (PRRS) viruses are a major cause of disease and economic loss in pigs worldwide. High genetic diversity among PRRSV strains is problematic for successful disease control by vaccination. Mosaic
Externí odkaz:
https://doaj.org/article/d3416e7fc19b49b197174a64cf0eec8b
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
Scientific Reports
Scientific Reports
Zika virus (ZIKV), a flavivirus transmitted primarily by infected mosquitos, can cause neurological symptoms such as Guillian–Barré syndrome and microcephaly. We developed several vaccinia virus (VACV) vaccine candidates for ZIKV based on replicat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76deb5ca1674cb2fad898633e839660a
https://doaj.org/article/0579b072da9c435fb3f374dfe50845f0
https://doaj.org/article/0579b072da9c435fb3f374dfe50845f0
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 17, Iss, Pp 731-738 (2020)
Molecular Therapy. Methods & Clinical Development
Molecular Therapy. Methods & Clinical Development
Vaccinia virus (VACV) was successfully used as a vaccine in the smallpox eradication campaign. Since then, it has been widely used in the development of vaccine and therapeutic vectors. However, methods of generating and purifying recombinant VACVs (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ddfdcdd37eb557e6c27f318d8af99e3
https://doi.org/10.1016/j.omtm.2020.03.026
https://doi.org/10.1016/j.omtm.2020.03.026
Publikováno v:
Biophysical Journal
The ongoing COVID-19 pandemic is a global public health emergency requiring urgent development of efficacious vaccines. While concentrated research efforts are underway to develop antibody-based vaccines that would neutralize SARS-CoV-2, and several
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5fb0c6e6ea0b87df1a00ec01500a2aef
https://pubmed.ncbi.nlm.nih.gov/34767789
https://pubmed.ncbi.nlm.nih.gov/34767789
Autor:
Caitlin Jeanette Hagen, Brittany Jasperse, Allison Titong, Paulo H. Verardi, Caitlin M. O’Connell
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 4, p e0230711 (2020)
PLoS ONE, Vol 15, Iss 4, p e0230711 (2020)
Vaccinia virus (VACV) has been used extensively as the vaccine against smallpox and as a viral vector for the development of recombinant vaccines and cancer therapies. Replication-competent, non-attenuated VACVs induce strong, long-lived humoral and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c2a22c47c9a8d2ecc481df2b48bb8ed
http://europepmc.org/articles/PMC7117657
http://europepmc.org/articles/PMC7117657
Autor:
J.D. Smith, Joan A. Smyth, Y. Pan, Paulo H. Verardi, Junru Cui, Caitlin M. O’Connell, Antonio E. Garmendia
Publikováno v:
Vaccine Reports. 6:77-85
The great genetic and antigenic diversity of PRRSV, an RNA virus that causes PRRS, makes the control of this disease very difficult. To achieve broad protection to infection with this divergent virus, two T-cell mosaic sequences were designed based o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e061ff4633e8dd5398fd7fa3cb55b3e